LIANY
Price
$0.38
Change
-$0.00 (-0.00%)
Updated
May 21 closing price
Capitalization
41.06M
82 days until earnings call
SER
Price
$5.93
Change
+$0.52 (+9.61%)
Updated
May 22, 03:50 PM (EDT)
Capitalization
53.92M
Interact to see
Advertisement

LIANY vs SER

Header iconLIANY vs SER Comparison
Open Charts LIANY vs SERBanner chart's image
LianBio
Price$0.38
Change-$0.00 (-0.00%)
Volume$25.8K
Capitalization41.06M
Serina Therapeutics
Price$5.93
Change+$0.52 (+9.61%)
Volume$250
Capitalization53.92M
LIANY vs SER Comparison Chart
Loading...
View a ticker or compare two or three
VS
LIANY vs. SER commentary
May 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LIANY is a Hold and SER is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
May 23, 2025
Stock price -- (LIANY: $0.38 vs. SER: $5.41)
Brand notoriety: LIANY and SER are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LIANY: 40% vs. SER: 229%
Market capitalization -- LIANY: $41.06M vs. SER: $53.92M
LIANY [@Biotechnology] is valued at $41.06M. SER’s [@Biotechnology] market capitalization is $53.92M. The market cap for tickers in the [@Biotechnology] industry ranges from $305.18B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LIANY’s FA Score shows that 1 FA rating(s) are green whileSER’s FA Score has 0 green FA rating(s).

  • LIANY’s FA Score: 1 green, 4 red.
  • SER’s FA Score: 0 green, 5 red.
According to our system of comparison, LIANY is a better buy in the long-term than SER.

Price Growth

LIANY (@Biotechnology) experienced а +90.10% price change this week, while SER (@Biotechnology) price change was -3.57% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.03%. For the same industry, the average monthly price growth was +7.67%, and the average quarterly price growth was -1.33%.

Reported Earning Dates

LIANY is expected to report earnings on Aug 12, 2025.

SER is expected to report earnings on Mar 24, 2025.

Industries' Descriptions

@Biotechnology (+5.03% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

FUNDAMENTALS
Fundamentals
SER($53.9M) has a higher market cap than LIANY($41.1M). LIANY YTD gains are higher at: 43.396 vs. SER (7.984).
LIANYSERLIANY / SER
Capitalization41.1M53.9M76%
EBITDAN/AN/A-
Gain YTD43.3967.984544%
P/E RatioN/A1.60-
RevenueN/AN/A-
Total CashN/A3.19M-
Total DebtN/A11.5M-
FUNDAMENTALS RATINGS
SER: Fundamental Ratings
SER
OUTLOOK RATING
1..100
88
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
49
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SCSIX39.07N/A
N/A
Sterling Capital SmCp Val R6
MSEPX21.86N/A
N/A
Morgan Stanley Inst Emerging Mkts C
BIERX25.22N/A
N/A
Brandes International Equity R6
BPGSX13.17N/A
N/A
Boston Partners Global Sustainablty Ins
LAFPX19.18N/A
N/A
Lord Abbett Affiliated P

LIANY and

Correlation & Price change

A.I.dvisor indicates that over the last year, LIANY has been closely correlated with SER. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if LIANY jumps, then SER could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LIANY
1D Price
Change %
LIANY100%
N/A
SER - LIANY
69%
Closely correlated
-5.26%
GERN - LIANY
53%
Loosely correlated
-3.60%
TRML - LIANY
28%
Poorly correlated
-6.73%
OTLK - LIANY
23%
Poorly correlated
-4.12%
MTNB - LIANY
21%
Poorly correlated
+1.30%
More

SER and

Correlation & Price change

A.I.dvisor indicates that over the last year, SER has been closely correlated with LIANY. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if SER jumps, then LIANY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SER
1D Price
Change %
SER100%
-5.26%
LIANY - SER
69%
Closely correlated
N/A
GERN - SER
65%
Loosely correlated
-3.60%
XTLB - SER
59%
Loosely correlated
-4.55%
ELVN - SER
37%
Loosely correlated
-2.59%
TOVX - SER
34%
Loosely correlated
+5.46%
More